Treatment of posttransplantation diabetes mellitus with anti-CD20 monoclonal antibodies

被引：0
|
作者：
Vandenbosch, K [1 ]
Champagne, MA [1 ]
Gonthier, M [1 ]
Moghrabi, A [1 ]
Vachon, MF [1 ]
Duval, M [1 ]
机构：
[1] Hop St Justine, Montreal, PQ H3T 1C5, Canada
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
192
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [31] Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
    Okroj, Marcin
    Osterborg, Anders
    Blom, Anna M.
    CANCER TREATMENT REVIEWS, 2013, 39 (06) : 632 - 639
  • [32] The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
    Evers, Mitchell
    Jak, Margot
    Leusen, J. H. W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (09) : 973 - 982
  • [33] Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders
    Dierickx, Daan
    Delannoy, Andre
    Saja, Khalid
    Verhoef, Gregor
    Provan, Drew
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (03) : 278 - 291
  • [34] Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YES
    Zecca, Chiara
    Gobbi, Claudio
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1173 - 1175
  • [35] BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naive elderly patients with CLL
    Rogers, Andrew
    Woyach, Jennifer A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [36] Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary
    Lycke, Jan
    Svenningsson, Anders
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1177 - 1178
  • [37] Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab)
    Marzano, Angelo V.
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    Caputo, Ruggero
    DERMATOLOGY, 2007, 214 (04) : 310 - 318
  • [38] Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
    Herrmann, G
    Engert, A
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (03) : 602 - 603
  • [39] Is there a role for anti-CD20 antibodies in CLL?
    Shah, Harsh R.
    Stephens, Deborah M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 68 - 75
  • [40] Clinical applications of anti-CD20 antibodies
    Gopal, AK
    Press, OW
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (05): : 445 - 450
12345